Filing Details
- Accession Number:
- 0001562180-20-004628
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-22 21:58:00
- Reporting Period:
- 2020-06-18
- Accepted Time:
- 2020-06-22 21:58:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1603756 | Axonics Modulation Technologies Inc. | AXNX | Surgical & Medical Instruments & Apparatus (3841) | 454744083 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1756438 | L. Danny Dearen | 26 Technology Drive Irvine CA 92618 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-18 | 27,749 | $1.42 | 84,240 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-06-18 | 2,251 | $1.32 | 86,491 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-18 | 30,000 | $39.26 | 56,491 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-06-22 | 2,015 | $1.42 | 58,506 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-06-22 | 8,890 | $1.32 | 67,396 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-06-22 | 34,095 | $1.63 | 101,491 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-22 | 45,000 | $38.11 | 56,491 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-18 | 27,749 | $0.00 | 27,749 | $1.42 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-18 | 2,251 | $0.00 | 2,045 | $1.32 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 34,095 | $0.00 | 34,095 | $1.63 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 2,015 | $0.00 | 2,015 | $1.42 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-22 | 8,890 | $0.00 | 8,890 | $1.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
16,895 | 2027-08-25 | No | 4 | M | Direct | |
17,067 | 2027-07-05 | No | 4 | M | Direct | |
35,505 | 2028-03-30 | No | 4 | M | Direct | |
14,880 | 2027-08-25 | No | 4 | M | Direct | |
8,177 | 2027-05-22 | No | 4 | M | Direct |
Footnotes
- This sale was pursuant to a 10b5-1 plan adopted by the reporting person on March 23, 2020.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 21, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 21, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on July 5, 2017, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of July 5, 2017, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
- The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting on March 30, 2018, and the remainder vesting at a rate of 1/36th per month commencing upon the one-year anniversary of March 30, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.